4.7 Article

m6Acancer-Net: Identification of m6A-mediated cancer driver genes from gene-site heterogeneous network

期刊

METHODS
卷 203, 期 -, 页码 125-138

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymeth.2022.04.002

关键词

M(6)A methylation; Driver gene; Heterogeneous network; Random walk with restart; Heat diffusion

资金

  1. China Postdoctoral Science Foundation [2020M683568]
  2. National Natural Science Foundation of China [61873202, 62173271]

向作者/读者索取更多资源

Researchers propose a novel network-based approach (m(6)Acancer-Net) to identify m(6)A-mediated driver genes and their associated networks in specific cancers. By integrating multiple data sources, this method can reliably identify functionally significant m(6)A-mediated driver genes in specific cancers, facilitating a deeper understanding of the regulatory and therapeutic mechanisms of cancer driver genes at the epitranscriptome level.
N-6-methyladenosine (m(6)A) is the most abundant eukaryotic modification internal mRNA, which plays the crucial roles in the occurrence and development of cancer. However, current knowledge about m(6)A-mediated functional circuit and key genes targeted by m(6)A methylation in cancer is mostly elusive. Thus, here we proposed a novel network-based approach (called m(6)Acancer-Net) to identify m(6)A-mediated driver genes and their associated network in specific type of cancer, such as acute myeloid leukemia. m(6)A-mediated cancer driver genes are defined as genes mediated by m(6)A methylation, significantly mutated, and functionally interacted in cancer. m(6)Acancer-Net identified the m(6)A-mediated cancer driver genes by combining gene functional interaction network with RNA methylation, gene expression and mutation information. A cancer-specific gene-site heterogeneous network was firstly constructed by connecting the m(6)A site co-methylation network with the functional interaction pruned gene co-expression network generated from large scale gene expression profile of specific cancer. Then, the functional m(6)A-mediated genes were identified by selecting the m(6)A regulators as seed genes to perform the random walk with restart algorithm on the gene-site heterogeneous network. Finally, m(6)A-mediated cancer driver gene subnetworks were constructed by performing the heat diffusion of mutation frequency for functional m(6)A-mediated genes in protein-protein interaction networks. The experimental results of m(6)AcancerNet on the acute myeloid leukemia (AML) and glioblastoma multiforme (GBM) data from TCGA project show that the m(6)A-mediated caner driver genes identified by m(6)Acancer-Net are targeted by m(6)A regulators, and mediate significant cancer-related pathways. They play crucial roles in development and prognostic stratification of cancer. Moreover, 15 m(6)A-mediated cancer driver genes identified in AML are validated by literatures to mediate AML progress, and 14 m(6)A-mediated cancer driver genes identified in GBM are validated by literatures to participate in development of GBM. m(6)Acancer-Net is reliable to identify the functionally significant m(6)A-mediated driver genes in specific cancer, and it can effectively facilitate the understanding of regulatory and therapeutic mechanism of cancer driver genes in epitranscriptome layer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据